Results
|
1.
|
A prospective study of leukocyte telomere length and risk of type 2 diabetes in postmenopausal women. MedStar authors:
Citation: - Diabetes. 61(11):2998-3004, 2012 Nov.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Chen BH, Chen Y, Curb JD, Howard BV, Kang M, Liu S, Lu X, Manson JE, Margolis KL, Phillips LS, Song Y, Stefanick ML, Tinker LF, You NC
|
|
2.
|
A Low-Fat Dietary Pattern and Diabetes: A Secondary Analysis From the Women's Health Initiative Dietary Modification Trial. MedStar authors:
Year: 2017
Citation: - Diabetes Care. 41(4):680-687, 2018 04.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Allison M, Aragaki AK, Hingle MD, Howard BV, Johnson KC, Manson JE, Prentice RL, Shadyab AH, Shikany JM, Snetselaar LG, Thomson CA, Tinker LF, Zaslavsky O
|
|
3.
|
Multiple Healthful Dietary Patterns and Type 2 Diabetes in the Women's Health Initiative. MedStar authors:
Year: 2016
Citation: - American Journal of Epidemiology. 183(7):622-33, 2016 Apr 1.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
- Research Support, U.S. Gov't, Non-P.H.S.
- Research Support, U.S. Gov't, P.H.S.
All authors: - Cespedes EM, Garcia L, Hingle M, Howard BV, Hu FB, Levitan EB, Li W, Manson JE, Neuhouser ML, Phillips LS, Redline S, Rhee JJ, Rosner B, Tinker L, Van Horn L, Waring ME
|
|
4.
|
Plasma Ceramide Species Are Associated with Diabetes Risk in Participants of the Strong Heart Study. MedStar authors:
- Howard, Barbara V
- Umans, Jason G
Year: 2020
Citation: - Journal of Nutrition. 150(5):1214-1222, 2020 05 01.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Fretts AM, Hoofnagle A, Howard BV, Jensen PN, King IB, Lemaitre RN, McKnight B, Siscovick DS, Sitlani C, Sotoodehnia N, Umans J, Yu C
|
|
5.
|
The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up. MedStar authors:
- Aroda, Vanita R
- Ratner, Robert E
Year: 2015
Citation: - Journal of Clinical Endocrinology & Metabolism. 100(4):1646-53, 2015 Apr.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Multicenter Study
- Observational Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Ackermann RT, Aroda VR, Barrett-Connor E, Christophi CA, Delahanty LM, Diabetes Prevention Program Research Group, Edelstein SL, Herman WH, Knowler WC, Montez MG, Ratner RE, Zhang P, Zhuo X
|
|
6.
|
|
|
7.
|
Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study. MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(9):2622-31, 2014 Sep.
All authors: - Diabetes Prevention Program Research Group, Goldberg RB, Hamman RF, Horton E, Kitabchi A, Larkin M, Mather KJ, Montez MG, Orchard TJ, Perreault L, Temprosa M, Thayer D
|
|
8.
|
Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). MedStar authors:
- Fatemi, Omid
- Yuriditsky, Eugene
Citation: - American Journal of Cardiology. 114(8):1217-22, 2014 Oct 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
All authors: - Basile J, Bigger T, Cushman W, Fatemi O, Goff D, Morgan T, Papademetriou V, Soliman EZ, Thomas A, Tsachris D, Tsioufis C, Yuriditsky E
|
|
9.
|
Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS). MedStar authors:
Year: 2017
Citation: - Diabetic Medicine. 34(12):1747-1755, 2017 Dec.
Institution: - MedStar Health Research Institute
Medline publication type:
All authors: - Aroda VR, Barrett-Connor E, Dabelea D, Dagogo-Jack S, Hamman RF, Kahn SE, Knowler WC, Mather KJ, Pan Q, Perreault L, The Diabetes Prevention Program Research Group
|
|
10.
|
Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW. MedStar authors:
Year: 2014
Citation: - Diabetes Care. 37(6):1706-11, 2014 Jun.
Institution: - MedStar Health Research Institute
Medline publication type:
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.
All authors: - Banerji M, Bray GA, Buchanan TA, Clement SC, DeFronzo RA, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Reaven PD, Schwenke DC, Stentz FB, Tripathy D
|
|
11.
|
Transcatheter versus surgical aortic valve replacement in patients with diabetes and severe aortic stenosis at high risk for surgery: an analysis of the PARTNER Trial (Placement of Aortic Transcatheter Valve). MedStar authors:
Year: 2014
Citation: - Journal of the American College of Cardiology. 63(11):1090-9, 2014 Mar 25.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
All authors: - Arnold SV, Kirtane AJ, Kodali S, Leon MB, Lindman BR, Maniar HS, McAndrew TC, Pibarot P, Smith CR, Suri RM, Svensson LG, Thourani VH, Tuzcu EM, Waksman R, Zajarias A
|
|
12.
|
|
|
13.
|
Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative. MedStar authors:
Year: 2021
Citation: - Cancer. 127(4):598-608, 2021 02 15.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Banack HR, Barac A, Beebe-Dimmer JL, Caan BJ, Chlebowski RT, Foraker R, Hastert TA, Hovsepyan G, Liu S, Luo J, Manson JE, Neuhouser ML, Okwuosa TM, Pan K, Qi L, Ruterbusch JJ, Shadyab AH, Simon MS, Thomson CA, Wactawski-Wende J, Waheed N
|
|
14.
|
|
|
15.
|
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. MedStar authors:
Year: 2018
Citation: - New England Journal of Medicine. 379(12):1107-1117, 2018 09 20.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bohula EA, Bonaca MP, Brown C, Budaj A, CAMELLIA-TIMI 61 Steering Committee and Investigators, Dhadda S, Fanola CL, Francis B, Garcia-Castillo A, Gupta M, Im K, Inzucchi SE, Keech AC, Kuder J, Leiter LA, McGuire DK, Miao W, Patel T, Perdomo C, Qamar A, Ruff CT, Sabatine MS, Scirica BM, Smith SR, Weissman NJ, White HD, Wiviott SD
|